Literature DB >> 21937587

Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.

Sun Yung1, Maria Ledran, Inmaculada Moreno-Gimeno, Ana Conesa, David Montaner, Joaquín Dopazo, Ian Dimmick, Nicholas J Slater, Lamin Marenah, Pedro J Real, Iliana Paraskevopoulou, Viviana Bisbal, Deborah Burks, Mauro Santibanez-Koref, Ruben Moreno, Joanne Mountford, Pablo Menendez, Lyle Armstrong, Majlinda Lako.   

Abstract

Understanding the transcriptional cues that direct differentiation of human embryonic stem cells (hESCs) and human-induced pluripotent stem cells to defined and functional cell types is essential for future clinical applications. In this study, we have compared transcriptional profiles of haematopoietic progenitors derived from hESCs at various developmental stages of a feeder- and serum-free differentiation method and show that the largest transcriptional changes occur during the first 4 days of differentiation. Data mining on the basis of molecular function revealed Rho-GTPase signalling as a key regulator of differentiation. Inhibition of this pathway resulted in a significant reduction in the numbers of emerging haematopoietic progenitors throughout the differentiation window, thereby uncovering a previously unappreciated role for Rho-GTPase signalling during human haematopoietic development. Our analysis indicated that SCL was the 11th most upregulated transcript during the first 4 days of the hESC differentiation process. Overexpression of SCL in hESCs promoted differentiation to meso-endodermal lineages, the emergence of haematopoietic and erythro-megakaryocytic progenitors and accelerated erythroid differentiation. Importantly, intrasplenic transplantation of SCL-overexpressing hESC-derived haematopoietic cells enhanced recovery from induced acute anaemia without significant cell engraftment, suggesting a paracrine-mediated effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937587     DOI: 10.1093/hmg/ddr431

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  12 in total

1.  SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

Authors:  Miguel G Toscano; Oscar Navarro-Montero; Veronica Ayllon; Veronica Ramos-Mejia; Xiomara Guerrero-Carreno; Clara Bueno; Tamara Romero; Mar Lamolda; Marien Cobo; Francisco Martin; Pablo Menendez; Pedro J Real
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

2.  SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.

Authors:  Pedro J Real; Gertrudis Ligero; Veronica Ayllon; Veronica Ramos-Mejia; Clara Bueno; Ivan Gutierrez-Aranda; Oscar Navarro-Montero; Majlinda Lako; Pablo Menendez
Journal:  Mol Ther       Date:  2012-04-10       Impact factor: 11.454

Review 3.  New insights into the epitranscriptomic control of pluripotent stem cell fate.

Authors:  Young Hyun Che; Hojae Lee; Yong Jun Kim
Journal:  Exp Mol Med       Date:  2022-10-21       Impact factor: 12.153

4.  Discovery of consensus gene signature and intermodular connectivity defining self-renewal of human embryonic stem cells.

Authors:  Jeffrey J Kim; Omar Khalid; AmirHosien Namazi; Thanh G Tu; Omid Elie; Connie Lee; Yong Kim
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

Review 5.  Potential for pharmacological manipulation of human embryonic stem cells.

Authors:  Stuart P Atkinson; Majlinda Lako; Lyle Armstrong
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells.

Authors:  Nicole M Kane; Lynsey Howard; Betty Descamps; Marco Meloni; John McClure; Ruifang Lu; Angela McCahill; Christopher Breen; Ruth M Mackenzie; Christian Delles; Joanne C Mountford; Graeme Milligan; Costanza Emanueli; Andrew H Baker
Journal:  Stem Cells       Date:  2012-04       Impact factor: 6.277

Review 7.  Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

Authors:  Weijie Ma; Barbara M Gilligan; Jianda Yuan; Tianhong Li
Journal:  J Hematol Oncol       Date:  2016-05-27       Impact factor: 17.388

8.  A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.

Authors:  K Tilgner; I Neganova; I Moreno-Gimeno; J Y Al-Aama; D Burks; S Yung; C Singhapol; G Saretzki; J Evans; V Gorbunova; A Gennery; S Przyborski; M Stojkovic; L Armstrong; P Jeggo; M Lako
Journal:  Cell Death Differ       Date:  2013-05-31       Impact factor: 15.828

9.  Reprogramming and genome integrity: role of non-homologous end joining.

Authors:  P Salomoni
Journal:  Cell Death Differ       Date:  2013-10       Impact factor: 15.828

10.  Differential variability and correlation of gene expression identifies key genes involved in neuronal differentiation.

Authors:  Tatsuya Ando; Ryuji Kato; Hiroyuki Honda
Journal:  BMC Syst Biol       Date:  2015-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.